Quick Summary
Zurig 80mg Tablet
Last updated on 31 Mar 2026 | 09:31 AM (IST)
₹457
MRP: ₹570.84
(You Save ₹113.84)
30 TABLET(s) IN A STRIP
20% OFF
₹457
MRP: ₹570.84
Inclusive of all taxes
20% Off
Product Discontinued
Dispatch: Today
Order In: 0h 0m 0s
0h 0m 0s
Order before timer ends to ensure your medicine is dispatched at...
Substitutes
Unuric 80mg Tablet
CONCORD BIOTECH...
₹ 16.50/tablet
9% costlier
Febutaz 80mg Tablet
SUN PHARMACEUTI...
₹ 23.40/tablet
54% costlier


Introduction
Zurig 80mg Tablet is a medication belonging to the class of xanthine oxidase inhibitors and contains the active ingredient febuxostat. It is primarily prescribed for the treatment of gout, a form of arthritis caused by excess uric acid build-up in the body. Patients with gout often experience severe pain, swelling, tenderness, and stiffness in the affected joints, most commonly in the toe joint, heels, knees, wrists, fingers, and even the ears. In addition to gout management, Zurig 80mg is also used to lower uric acid levels in patients undergoing chemotherapy for blood cancers.
The Zurig 80mg tablet composition includes febuxostat as the active ingredient, which works by reducing uric acid production in the body. When discussing Zurig 80mg vs febuxostat, it is important to note that Zurig 80mg itself is a febuxostat-based medicine, making it therapeutically similar to other brands that contain the same ingredient. If this formulation is not available, doctors may recommend a Zurig 80mg substitute with equivalent efficacy.
Regarding usage, the Zurig 80mg tablet dosage is usually once daily, but the exact dose and duration should always be determined by a healthcare provider. Patients often search for information on Zurig 80mg tablet how to take, and the general advice is to swallow the tablet whole with water, with or without food, exactly as prescribed.
In terms of effectiveness, the Zurig 80mg review highlights that many patients report fewer gout flare-ups and significant relief from pain when taken under proper medical guidance. However, consistency in taking the medicine and lifestyle modifications, such as dietary adjustments and hydration, play an equally important role in long-term results.
Lastly, the Zurig 80 mg price can vary depending on the manufacturer, pharmacy, and region of purchase. Patients are often advised to compare costs or look for Zurig 80mg substitutes to find the most affordable option while maintaining treatment quality.
Uses
Zurig tablet uses are
- Treatment of Gout
- Treatment of Chemotherapy for blood cancer
How Zurig 80mg Tablet works
It works by inhibiting the enzyme called xanthine oxidase inhibitors, which are responsible for the production of uric acid in the body. By inhibiting this enzyme, this drug reduces the production of uric acid, which can help prevent gout attacks and the formation of uric acid crystals in the joints and other tissues.
Interaction of Zurig 80mg Tablet with other drugs
Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Zurig 80mg tablet and reduce effectiveness by causing undesirable side effects.
Storage conditions
- Store Zurig 80mg tablet in the original package at room temperature (15°C to 30°C).
- Keep it out of reach from children.
How to take Zurig 80mg Tablet
Your doctor will decide the dose and duration of Zurig 80mg tablet based on the disease condition and other factors. Always take this medicine as prescribed by your doctor. Take the tablet at the same time every day, with or without food. Do not chew, crush, or break the tablet. Swallow the whole tablet with water. If you forgot to take the tablet, simply take your next dose at the scheduled time. Do not take a double dose to make up for a forgotten dose.
Safety Advice for Zurig 80mg Tablet
Breast Feeding
It is not known if Zurig 80mg tablet passes into your breast milk or if it will affect your baby. Please consult your doctor before breastfeeding.
Alcohol
Consuming alcohol may affect the effectiveness of Zurig 80mg tablet. Stop consuming alcohol if you are taking this medicine.
Liver
Inform your doctor if you have any liver problems before taking Zurig 80mg tablet. Regular monitoring of liver function tests is recommended.
Lungs
It is not known whether Zurig 80mg tablet can be administered to patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.
Driving
It is unsafe to drive vehicles or operate heavy machinery after taking Zurig 80mg tablet, it may cause dizziness and impair your concentration.
Pregnancy
Zurig 80mg tablet is not recommended for pregnant women as it may cause fetal harm. Consult your doctor if you are pregnant or planning for pregnancy during the treatment.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Zurig 80mg side effects are
Common
- Diarrhea
- Headache
- Rash
- Nausea
- Increase in gout symptoms
- Localised swelling due to retention of fluids in tissues
- Abnormal liver function
- Kidney problems
Expert tips
-
Pregnancy warning: Zurig 80 mg tablet is not recommended for pregnant women, as it may harm the fetus. If you're pregnant or planning to become pregnant, consult your doctor.
-
Breastfeeding: It is unknown whether the drug passes into breast milk, so breastfeeding during treatment is not recommended.
-
Purine-rich food to avoid: Foods high in purines—such as spinach, meat (especially red meat like beef and pork), mushrooms, and cauliflower—should be avoided to reduce the risk of gout.
-
Safe food options: Low-purine foods like fruits, vegetables, and whole grains are generally safe to eat.
-
Hydration: Drink plenty of fluids while taking this medication to help prevent kidney stones, a possible side effect.
-
Alcohol consumption: Avoid or limit alcohol intake, as it may increase the risk of gout flares.
FAQs about Zurig 80mg Tablet
Q1.
Can I drink alcohol while taking Zurig 80mg tablet?
It is generally recommended to avoid drinking alcohol while taking Zurig 80mg tablet, as alcohol can increase the risk of liver damage.
Q2.
Why do cancer patients develop high uric acid?
This can happen when a large number of cancer cells die rapidly in a short period of time. When the cancer cells die, they release uric acid into the bloodstream. As a result, the kidneys are unable to eliminate the uric acid quickly enough, leading to high uric acid levels in the body.
Q3.
What is the recommended dose of Zurig 80mg tablet?
The recommended starting dose is 40 mg once daily. If uric acid levels remain high after two to four weeks, the dose may be increased to 80 mg once daily. The maximum recommended dose is 120 mg once daily.
Q4.
Can I stop taking Zurig 80mg tablet if I feel better and have no pain or swelling in my joints?
No, stopping the medicine without a doctor's advice can cause the uric acid levels to increase again, and gout attacks may return.
Q5.
What you should know while taking Zurig 80mg tablet?
You should have cautious while taking Zurig 80mg tablet, it can cause heart problems like breathing difficulty, chest pain, rapid or irregular heartbeat, and dizziness.
Fact Box of Zurig 80mg Tablet
|
Molecule name |
Febuxostat |
|
Therapeutic class |
Antihyperuricemic |
|
Pharmacological class |
Xanthine oxidase inhibitors |
|
Indications |
1. Treatment of Gout 2. Treatment of Chemotherapy for blood cancers |
References
- Accord healthcare limited, Electronic medicines compendium (EMC), [Revised on July 2020] [ Accessed on 12th July 2021], https://www.medicines.org.uk/emc/files/pil.10184.pdf
- Takeda Pharmaceuticals America, Inc, US Food and Drug Administration, [Revised on March 2013] [ Accessed on 12th July 2021], https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021856s011lbl.pdf
- Takai M;Yamauchi T;Ookura M;Matsuda Y;Tai K;Kishi S;Yoshida A;Iwasaki H;Nakamura T;Ueda T; Febuxostat for management of tumour lysis syndrome including its effects on levels of purine metabolites in patients with haematological malignancies - a single institution's, pharmacokinetic and pilot prospective study, Anticancer research. U.S. National Library of Medicine. Available at: https://pubmed.ncbi.nlm.nih.gov/25503162/(Accessed on March 25, 2023).
- Takai, M. et al. (2014) Controlling serum uric acid using febuxostat in cancer patients at risk of tumor lysis syndrome, Oncology letters. U.S. National Library of Medicine. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4156226/ (Accessed on March 25, 2023).
- Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Anti-inflammatory, antipyretic, and analgesic agents; pharmacotherapy of gout, 12th edition, 2011, 1499.
- KD Tripathi, Essentials of Medical Pharmacology, Antirheumatoid and antigout drugs, 7th edition, 2013, 217.
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details

Written By
Dr. B. Deiva
Pharm D

Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 31 Mar 2026 | 09:31 AM (IST)

Want to know more?
Read Our Editorial Policy









